Head of Global Health Security at the Infectious Diseases Institute (IDI). He is the Chair of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Africa Network.

Since 2006, he has worked at IDI undertaking clinical pharmacology research in the fields of HIV, tuberculosis, malaria and health economics evaluations for interventions relevant to public health in developing countries. His is a clinical investigator on studies investigating drug-drug interactions between antiretroviral drugs and contraceptives, antiretroviral and anti-tuberculosis agents and antiretroviral and antimalarial drugs. Also, his research interests include pharmacokinetics of antiretroviral drugs in pregnancy and postpartum and traditional medicines.

Dr Lamorde is co-investigator on the Joint Mobile Emerging Diseases Intervention Clinical Capabilities (JMEDICC) consortium which aims to conduct clinical trials on investigational new drugs during filovirus outbreaks. He is Project Director of the CAPA-CT and CAPA-CT II projects (with funding from the European and Developing Countries Clinical Trials Partnerships) that aim to establish capacity and conduct research on investigational therapeutics and novel diagnostics for filoviruses in Uganda.

Email: mlamorde@idi.co.ug